BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 30448857)

  • 1. From molecules to medicines: the dawn of targeted therapies for genetic epilepsies.
    Demarest ST; Brooks-Kayal A
    Nat Rev Neurol; 2018 Dec; 14(12):735-745. PubMed ID: 30448857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Editing and Modulation: the Holy Grail for the Genetic Epilepsies?
    Carpenter JC; Lignani G
    Neurotherapeutics; 2021 Jul; 18(3):1515-1523. PubMed ID: 34235638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haploinsufficiency, Dominant Negative, and Gain-of-Function Mechanisms in Epilepsy: Matching Therapeutic Approach to the Pathophysiology.
    Carvill GL; Matheny T; Hesselberth J; Demarest S
    Neurotherapeutics; 2021 Jul; 18(3):1500-1514. PubMed ID: 34648141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personalized medicine in genetic epilepsies - possibilities, challenges, and new frontiers.
    Helbig I; Ellis CA
    Neuropharmacology; 2020 Aug; 172():107970. PubMed ID: 32413583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From next-generation sequencing to targeted treatment of non-acquired epilepsies.
    Møller RS; Hammer TB; Rubboli G; Lemke JR; Johannesen KM
    Expert Rev Mol Diagn; 2019 Mar; 19(3):217-228. PubMed ID: 30661434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precision medicine in genetic epilepsies: break of dawn?
    Reif PS; Tsai MH; Helbig I; Rosenow F; Klein KM
    Expert Rev Neurother; 2017 Apr; 17(4):381-392. PubMed ID: 27781560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in epilepsy genetics.
    Orsini A; Zara F; Striano P
    Neurosci Lett; 2018 Feb; 667():4-9. PubMed ID: 28499889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From Genetic Testing to Precision Medicine in Epilepsy.
    Striano P; Minassian BA
    Neurotherapeutics; 2020 Apr; 17(2):609-615. PubMed ID: 31981099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precision therapy in the genetic epilepsies of childhood.
    Byrne S; Enright N; Delanty N
    Dev Med Child Neurol; 2021 Nov; 63(11):1276-1282. PubMed ID: 34089185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Developments in CRISPR/Cas-based Functional Genomics and their Implications for Research Using Zebrafish.
    Prykhozhij SV; Caceres L; Berman JN
    Curr Gene Ther; 2017; 17(4):286-300. PubMed ID: 29173171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalised genome editing - The future for corneal dystrophies.
    Moore CBT; Christie KA; Marshall J; Nesbit MA
    Prog Retin Eye Res; 2018 Jul; 65():147-165. PubMed ID: 29378321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monogenic Epilepsies: Disease Mechanisms, Clinical Phenotypes, and Targeted Therapies.
    Guerrini R; Balestrini S; Wirrell EC; Walker MC
    Neurology; 2021 Oct; 97(17):817-831. PubMed ID: 34493617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Trial Design for Disease-Modifying Therapies for Genetic Epilepsies.
    Brock DC; Demarest S; Benke TA
    Neurotherapeutics; 2021 Jul; 18(3):1445-1457. PubMed ID: 34595733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Molecular Revolution in Cutaneous Biology: Emerging Landscape in Genomic Dermatology: New Mechanistic Ideas, Gene Editing, and Therapeutic Breakthroughs.
    Titeux M; Izmiryan A; Hovnanian A
    J Invest Dermatol; 2017 May; 137(5):e123-e129. PubMed ID: 28411843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applications of genome editing tools in precision medicine research.
    Li S; Yang YY; Qiu Y; Chen Y; Xu LW; Ding QR
    Yi Chuan; 2017 Mar; 39(3):177-188. PubMed ID: 28420614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Discoveries Drive Molecular Analyses and Targeted Therapeutic Options in the Epilepsies.
    Dhindsa RS; Goldstein DB
    Curr Neurol Neurosci Rep; 2015 Oct; 15(10):70. PubMed ID: 26319171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precision medicine and therapies of the future.
    Sisodiya SM
    Epilepsia; 2021 Mar; 62 Suppl 2(Suppl 2):S90-S105. PubMed ID: 32776321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A roadmap for precision medicine in the epilepsies.
    EpiPM Consortium
    Lancet Neurol; 2015 Dec; 14(12):1219-28. PubMed ID: 26416172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cell contributions to neurological disease modeling and personalized medicine.
    Liang N; Trujillo CA; Negraes PD; Muotri AR; Lameu C; Ulrich H
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt A):54-62. PubMed ID: 28576415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Model Program for Translational Medicine in Epilepsy Genetics.
    Smith LA; Ullmann JF; Olson HE; Achkar CM; Truglio G; Kelly M; Rosen-Sheidley B; Poduri A
    J Child Neurol; 2017 Mar; 32(4):429-436. PubMed ID: 28056630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.